Following petitions arguing the ban of ashwagandha leaves or extracts that contain leaf in health supplements bypassed formal regulatory amendment procedures under existing food safety frameworks, The Karnataka High Court has issued an interim stay and scheduled a follow-up hearing.

NPA members brought key supplement policy priorities directly to lawmakers, including concerns over state-level restrictions and mandatory product listing proposals.

A decades-old definition is under the microscope as FDA gathers input on dietary supplement ingredients and innovation.

A new House bill would require dietary supplement manufacturers to register products with FDA, reigniting debate between industry groups over transparency, regulatory burden, and the future of DSHEA oversight.

Congressional hearings, Supreme Court challenges, FDA petitions, and new state food-labeling proposals are intensifying action over supplement oversight, health claims, and consumer transparency.

NOW's latest round of industry quality testing of dietary supplements involved 35 oregano oil supplements sold on Amazon, and found nearly two-thirds failed potency standards.

The Government of India's restriction on ashwagandha leaves in nutritional supplements is sparking industry debate. Experts weigh safety, science, and supply chain impacts of the root-only directive.

Read up on all the latest news in the natural products industry, including new collabs, trade show news, and more.

India’s Ministry of Ayush and Food Safety and Standards Authority of India have issued aligned directives prohibiting ashwagandha leaves in supplements and foods, reinforcing root-only use, mandating plant-part labeling, and stepping up enforcement after years of non-compliance.